Kenny, here's a link to Dr. Mendell's presentation at the conference this summer:
Quite interesting.No adverse effects too.
The DMD trial would be an extension of the Becker trial.
Hi Moein: I don't think Dr. Mendell has shared the exact time line for that study publicly but my impression is that it would start recruiting within the next few months. He will be using the same Investigational New Drug protocol that was approved for BMD so that reduces the regulatory hurdles. At least that's the plan.